Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide Accuhaler in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group study.

Trial Profile

Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide Accuhaler in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group study.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 May 2013

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors HEXAL
  • Most Recent Events

    • 29 May 2013 Primary endpoint 'Forced-expiratory-volume-in-1-second' has been met.
    • 29 May 2013 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.
    • 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top